Sex disparities in gallstone disease: insights from the MAUCO prospective population-based cohort study.


Journal

BMJ open gastroenterology
ISSN: 2054-4774
Titre abrégé: BMJ Open Gastroenterol
Pays: England
ID NLM: 101660690

Informations de publication

Date de publication:
28 Sep 2024
Historique:
received: 02 05 2024
accepted: 23 07 2024
medline: 30 9 2024
pubmed: 30 9 2024
entrez: 29 9 2024
Statut: epublish

Résumé

To investigate factors associated with the prevalence and incidence of gallstone disease (GSD) in women and men of the MAUCO population-based prospective cohort. 8948 MAUCO participants (aged 38-74 years) underwent abdominal ultrasound at baseline (2015-2019); 4385 received follow-up ultrasound at years 2 or 4. Factors associated with prevalent GSD were assessed using Poisson multiple regression and with incident GSD using Cox regression models. GSD prevalence was 40.4% in women (13.1% gallstones, 27.3% cholecystectomies) and 17.1% in men (8.9% gallstones, 8.2% cholecystectomies). In men, GSD prevalence rate ratio (PRR) by age in >64 years was 3.85 (95% CI 3.00 to 4.94), doubling that of women's PRR 1.78 (95% CI 1.57 to 2.01). In women, waist circumference and diabetes were stronger GSD factors; a higher number of children and worse metabolic and socioeconomic conditions were also highlighted. GSD men had higher cardiovascular disease and a family history of GSD and gallbladder cancer. 198 GSD cases developed during follow-up, with incidence increasing by 2% (95% CI 1.005% to 1.03%) per each centimetre above the ideal waist circumference, statistically significant only in women. In men, age was the strongest factor for incidence, followed by a family history of GSD and low high-density lipoprotein increased incidence risk. GSD burden was high in this population; a third of women had their gallbladder removed, which may pose them at risk of other health problems. Abdominal obesity was the only preventable GSD risk factor, highlighting the need for effective public health policies promoting obesity reduction.

Identifiants

pubmed: 39343441
pii: bmjgast-2024-001457
doi: 10.1136/bmjgast-2024-001457
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Danae Rodriguez Gatta (D)

Departamento de Salud Pública, Facultad de Medicina, Pontificia Universidad Catolica de Chile, Santiago, Chile.
Advanced Center for Chronic Diseases, ACCDiS, Universidad de Chile and Pontificia Universidad Católica de Chile, Santiago, Chile.
London School of Hygiene and Tropical Medicine, London, UK.

Laura Huidobro (L)

Advanced Center for Chronic Diseases, ACCDiS, Universidad de Chile and Pontificia Universidad Católica de Chile, Santiago, Chile.
Facultad de Medicina, Universidad Católica del Maule, Talca, Chile.

Fanny Petermann-Rocha (F)

Centro de Investigación Biomédica, Facultad de Medicina, Universidad Diego Portales, Santiago, Chile.

Vanessa Van de Wyngard (V)

Departamento de Salud Pública, Facultad de Medicina, Pontificia Universidad Catolica de Chile, Santiago, Chile.
Advanced Center for Chronic Diseases, ACCDiS, Universidad de Chile and Pontificia Universidad Católica de Chile, Santiago, Chile.

Franco Godoy (F)

Departamento de Salud Pública, Facultad de Medicina, Pontificia Universidad Catolica de Chile, Santiago, Chile.
Advanced Center for Chronic Diseases, ACCDiS, Universidad de Chile and Pontificia Universidad Católica de Chile, Santiago, Chile.

Vicente Cid (V)

Departamento de Salud Pública, Facultad de Medicina, Pontificia Universidad Catolica de Chile, Santiago, Chile.
Advanced Center for Chronic Diseases, ACCDiS, Universidad de Chile and Pontificia Universidad Católica de Chile, Santiago, Chile.

Macarena Garrido (M)

Departamento de Salud Pública, Facultad de Medicina, Pontificia Universidad Catolica de Chile, Santiago, Chile.
Advanced Center for Chronic Diseases, ACCDiS, Universidad de Chile and Pontificia Universidad Católica de Chile, Santiago, Chile.

Paz Cook (P)

Departamento de Salud Pública, Facultad de Medicina, Pontificia Universidad Catolica de Chile, Santiago, Chile.
Advanced Center for Chronic Diseases, ACCDiS, Universidad de Chile and Pontificia Universidad Católica de Chile, Santiago, Chile.

Juan Carlos Roa (JC)

Departamento de Patología, Pontificia Universidad Catolica de Chile, Santiago, Chile.

Claudio Vargas (C)

Advanced Center for Chronic Diseases, ACCDiS, Universidad de Chile and Pontificia Universidad Católica de Chile, Santiago, Chile.
Universidad de Santiago de Chile, Santiago de Chile, Chile.

Juan Carlos Araya (JC)

Advanced Center for Chronic Diseases, ACCDiS, Universidad de Chile and Pontificia Universidad Católica de Chile, Santiago, Chile.
Departamento de Patología, Universidad de La Frontera, Temuco, Chile.

Sandra Cortes (S)

Departamento de Salud Pública, Facultad de Medicina, Pontificia Universidad Catolica de Chile, Santiago, Chile.
Advanced Center for Chronic Diseases, ACCDiS, Universidad de Chile and Pontificia Universidad Católica de Chile, Santiago, Chile.
Centro de Desarrollo Urbano Sustentable, CEDEUS, Pontificia Universidad Catolica de Chile, Santiago, Chile.

Francisco Cruz (F)

Departamento de Radiología, Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile.

Jill Koshiol (J)

Division of Cancer Epidemiology and Genetics, Infections and Immunoepidemiology, National Cancer Institute Division of Cancer Epidemiology and Genetics, Rockville, Maryland, USA.

Marco Arrese (M)

Advanced Center for Chronic Diseases, ACCDiS, Universidad de Chile and Pontificia Universidad Católica de Chile, Santiago, Chile.
Departamento de Gastroenterología, Facultad de Medicina, Pontificia Universidad Catolica de Chile, Santiago, Chile.
Centro de Envejecimiento y Regeneración (CARE), Departamento de Biología Celular y Molecular, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, Chile.

Catterina Ferreccio (C)

Departamento de Salud Pública, Facultad de Medicina, Pontificia Universidad Catolica de Chile, Santiago, Chile catferre@gmail.com.
Instituto de Salud Pública de Chile, Santiago, Chile.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH